QMS Medical Allied Services Valuation

Is QMSMEDI undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of QMSMEDI when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: QMSMEDI (₹107) is trading below our estimate of fair value (₹135.39)

Significantly Below Fair Value: QMSMEDI is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for QMSMEDI?

Key metric: As QMSMEDI is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for QMSMEDI. This is calculated by dividing QMSMEDI's market cap by their current earnings.
What is QMSMEDI's PE Ratio?
PE Ratio	19.5x
Earnings	₹98.16m
Market Cap	₹1.91b

QMSMEDI key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.9x
Enterprise Value/EBITDA	12.3x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does QMSMEDI's PE Ratio compare to its peers?

The above table shows the PE ratio for QMSMEDI vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	61.3x
MADHAVBAUG Vaidya Sane Ayurved Laboratories	36.3x	n/a	₹1.5b
543499 Achyut Healthcare	159.5x	n/a	₹1.1b
544143 Royal Sense	34.8x	n/a	₹977.6m
543916 Hemant Surgical Industries	14.7x	n/a	₹1.3b
QMSMEDI QMS Medical Allied Services	19.5x	n/a	₹1.9b

Price-To-Earnings vs Peers: QMSMEDI is good value based on its Price-To-Earnings Ratio (19.5x) compared to the peer average (61.3x).

Price to Earnings Ratio vs Industry

How does QMSMEDI's PE Ratio compare vs other companies in the IN Healthcare Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.1x	n/a	US$11.79m
516110 Family Care Hospitals	3.3x	n/a	US$4.41m
542918 Gian Life Care	5x	n/a	US$2.35m

No more companies available in this PE range

3 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: QMSMEDI is good value based on its Price-To-Earnings Ratio (19.5x) compared to the Indian Healthcare industry average (42.3x).

Price to Earnings Ratio vs Fair Ratio

What is QMSMEDI's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

QMSMEDI PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	19.5x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate QMSMEDI's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Medico Intercontinental

₹506.6m

Trades in pharmaceutical products.

539938

₹50.66

11.8%

-40.7%

Dr Lalchandani Labs

₹74.3m

Provides diagnostic and related healthcare tests and services in India.

541299

₹17.15

-4.7%

-51.0%

N G Industries

₹544.1m

Provides various healthcare services in India.

530897

₹162.40

-0.6%

-6.1%